The former high school football player who killed four people inside a Manhattan office tower that houses the headquarters of the NFL, and who blamed the league for hiding the dangers of brain ...

(TNS) — There is a surge of interest in career and technical education programs at the secondary school level, fueled by concerns about the cost of college and opportunities to make good money in jobs ...

There is a surge of interest in career and technical education programs at the secondary school level, fueled by concerns about the cost of college and opportunities to make good money in jobs that ...

Students are increasingly interested in focusing on digital technology, information technology, artificial intelligence, and cybersecurity in their career and technical education courses, according to ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

With the official release of Microsoft's latest database offering, let's see what was improved and what still needs some work. Today, at Ignite, Microsoft announced the general availability of SQL ...

The NFL season has been rife with tragedy—not that the league or its media partners have noticed. Cleveland Browns player Carl Nassib enters the bue tent during an NFL football game against the New ...

This story mentions suicide. Mental health resources can be found at the bottom of this story. The death of Dallas Cowboys defensive end Marshawn Kneeland from an apparent self-inflicted gunshot wound ...

Over the last two decades, career and technical education (CTE) has undergone significant reform and renewal, moving it from the margins to the center of education policy discussions. Long neglected ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...